Product Wiki · Recalls · EU Safety Gate (RAPEX)

Нз ВОз Boric Acid — recall SR/00072/26

EU Safety Gate (RAPEX) · Germany · 2026-01-16 · Serious risk

Machine-translated with AI — the facts come from the issuing authority’s own notice (linked on this page); this language version was translated automatically by an AI model and is not reviewed. The original-language notice is authoritative. How we use AI →
Agency
EU Safety Gate (RAPEX)
Recall identifier
SR/00072/26
Date of alert
2026-01-16
Country / jurisdiction
Germany
Risk level
Serious risk
Risk type
Chemical
Brand
VITATEKA
Product category
Chemical products
Product type
Boric acid
🔴 Serious hazard — Reported risk: Das Produkt ist Borsäure, die in Produkten, die Verbrauchern zugänglich sind, verboten ist. Borsäure kann die Fruchtbarkeit beeinträchtigen und das ungeborene Kind schädigen. Das Produkt entspricht nicht der REACH-Verordnung noch der Allgemeinen Produktsicherheitsverordnung.
Action taken by the authority
Type of economic operator taking notified measure
Retailer
Category of measure
Destruction of the product
Date of entry into force
27/10/2025
Machine translation. This page was translated automatically from the English record we hold of the issuing authority’s notice. The English original is shown below and the authority’s own notice is linked above — both take precedence over this translation.

Product Name (original English): Нз ВОз Boric Acid

Risk Description (original English): The product is boric acid, which is banned in products available to consumers. Boric acid may damage fertility and may damage the unborn child.

Primary source: https://ec.europa.eu/safety-gate-alerts/screen/webReport/alertDetail/10097065

Verify each fact at the issuing agency before acting. Recall scope, affected lots, and remediation instructions may be updated by the agency after our last sync.

ProductGuru indexes recall and safety-alert records from ~30 public agency registries. We are not lawyers, regulators or product-safety consultants. This page restates what the named agency published; consult the primary source above (or qualified counsel in your jurisdiction) before any commercial, medical or safety decision.